Indivior Pharmaceuticals, Inc. Stock London S.E.
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
London S.E.
19:35:04 24/07/2025 +04
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| Market Cap | 4.23B 3.76B 3.52B 3.21B 6.02B 407B 6.11B 42.45B 16.45B 208B 15.88B 15.54B 669B | P/E 2026 * |
9.64x | P/E 2027 * | 8.73x |
|---|---|---|---|---|---|
| Enterprise Value | 4.22B 3.75B 3.51B 3.2B 6B 406B 6.09B 42.32B 16.4B 207B 15.84B 15.49B 667B | EV / Sales 2026 * |
3.17x | EV / Sales 2027 * | 2.62x |
| Free-Float |
98.18% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% |
| 1 week | 1,160 |  | 1,264 |
| 1 month | 975.5 | | 1,264 |
| 3 years | 554.83 | | 2,020 |
| 5 years | 335 | | 2,020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +5.27% | +49.52% | -20.18% | 4.23B | |
| -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | |
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | |
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | |
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | |
| -1.04% | -2.56% | +32.88% | +96.82% | 185B | |
| Average | -0.66% | -0.36% | +36.03% | +49.59% | 418.21B | |
| Weighted average by Cap. | -0.24% | -0.35% | +38.06% | +69.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.18B 1.11B 1.01B 1.89B 128B 1.92B 13.36B 5.18B 65.39B 5B 4.89B 211B | 1.4B 1.24B 1.16B 1.06B 1.99B 135B 2.02B 14.04B 5.44B 68.71B 5.25B 5.14B 221B |
| Net income | 474M 422M 394M 359M 675M 45.68B 685M 4.76B 1.84B 23.28B 1.78B 1.74B 74.96B | 530M 471M 440M 402M 754M 51.04B 765M 5.32B 2.06B 26.02B 1.99B 1.95B 83.76B |
| Net Debt | -12.5M -11.12M -10.39M -9.47M -17.78M -1.2B -18.04M -125M -48.61M -614M -46.93M -45.91M -1.98B | -570M -507M -474M -432M -811M -54.9B -823M -5.72B -2.22B -27.98B -2.14B -2.09B -90.09B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
